default author photo

Shinobu Shimizu

Nagoya University - Department of Advanced Medicine

SCHOLARLY PAPERS

1

DOWNLOADS

263

TOTAL CITATIONS

1

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Efficacy and Safety of Rituximab in Refractory Chronic Inflammatory Demyelinating Polyneuropathy with Immunoglobulin G4 Autoantibodies: A Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase 2 Exploratory Trial (RECIPE Study)

Number of pages: 49 Posted: 25 Jul 2024
Masahiro Iijima, Shinobu Shimizu, Yuki Fukami, Masahiro Nakatochi, Masahiko Ando, Ryoji Nishi, Haruki Koike, Kenichi Kaida, Michiaki Koga, Takashi Kanda, Hidenori Ogata, Ryo Yamasaki, Jun-Ichi Kira, Masahiro Mori, Satoshi Kuwabara and Masahisa Katsuno
Nagoya University - Department of Advanced Medicine, Nagoya University - Department of Advanced Medicine, Kyushu University - Department of Neurology, Nagoya University - Department of Advanced Medicine, Nagoya University - Department of Advanced Medicine, Chiba University - Department of Neurology, Chiba University - Department of Neurology, National Defense Medical College, Yamaguchi University, Yamaguchi University, Kyushu University - Kyushu University Hospital, Kyushu University, Kyushu University - Department of Neurology, Chiba University - Department of Neurology, Chiba University - Department of Neurology and Nagoya University - Department of Neurology
Downloads 263 (310,057)
Citation 1

Abstract:

Loading...

Chronic inflammatory demyelinating polyneuropathy (CIDP), rituximab, autoimmune nodopathies, immunoglobulin G4 (IgG4) autoantibodies, neurofascin-155 (NF155), clinical trial